Andréanne Trottier, B.Sc. Marie-Claude Battista, Ph.D., David H. Geller, M.D., Ph.D., Brigitte Moreau, M.D., André C. Carpentier, M.D., Judith Simoneau-Roy, M.D., Jean-Patrice Baillargeon, M.D., M.Sc.
Vol 98, Issue 6, Pages 1627-1634
To assess metabolic and endocrine defects in girls genetically predisposed to polycystic ovary syndrome (PCOS).
Controlled cross-sectional study.
Nine girls, aged 8-14 years, having a first-degree relative diagnosed with PCOS (PCOSr) and 10 age-matched girls unrelated to PCOS.
Main outcome measure:
Insulin sensitivity (ISFSIVGTT) determined by frequently sampled IV glucose tolerance testing (GTT) and insulin-induced nonesterified fatty acid (NEFA) suppression, estimated by the log-linear slope of NEFA levels during the first 20 minutes of GTT.
In comparison to controls, PCOSr had higher body mass index (BMI) Z-score, waist circumference, and waist-to-height ratio. Levels of the androgen 17α-hydroxyprogesterone (17-OHP) were significantly increased in PCOSr, independent of adiposity, and inversely correlated with ISFSIVGTT. The ISFSIVGTT was decreased and the NEFA suppression was less steep in PCOSr compared with controls, independent of BMI and 17-OHP. The NEFA suppression was more pronounced with increasing ISFSIVGTT, independent of adiposity.
Girls at high risk of developing PCOS display increased adiposity and 17-OHP levels, but are mainly characterized by global insulin resistance and resistance to insulin-induced suppression of lipolysis that were independent of adiposity and 17-OHP levels. Therefore, genetic predisposition to PCOS may be related to early insulin resistance and adipocyte dysfunction.
Read the full text at: http://www.fertstert.org/article/S0015-0282(12)02077-8/fulltext